A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC in Adults With Ocular Myasthenia Gravis

NCT06558279 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

141

Enrollment

INDUSTRY

Sponsor class

Conditions

Myasthenia Gravis, Ocular

Interventions

COMBINATION_PRODUCT: Efgartigimod PH20 SC
OTHER: Placebo PH20 SC

Sponsor

argenx